Alam, R., Abdolmaleky, H. M., & Zhou, J. R. (2017). Microbiome, inflammation, epigenetic alterations, and mental diseases. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 174(6), 651–660. https://doi.org/10.1002/ajmg.b.32567.

 

Aldini, G., Altomare, A., Baron, G., Vistoli, G., Carini, M., Borsani, L., & Sergio, F. (2018). N-Acetylcysteine as an antioxidant and disulphide breaking agent: The reasons why. Free Radical Research, 52(7), 751–762. https://doi.org/10.1080/10715762.2018.1468564.

      American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.).

 

Anka, A. U., Tahir, M. I., Abubakar, S. D., Alsabbagh, M., Zian, Z., Hamedifar, H., Sabzevari, A., & Azizi, G. (2021). Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis, and management. Scandinavian Journal of Immunology, 93(4), e12998. https://doi.org/10.1111/sji.12998.

 

Bloch, M. H., & Mulqueen, J. M. (2014). Nutritional supplements for the treatment of ADHD. Child and Adolescent Psychiatric Clinics of North America, 23(4), 883–897. https://doi.org/10.1016/j.chc.2014.05.002.

 

Bonvento, G., & Bolaños, J. P. (2021). Astrocyte-neuron metabolic cooperation shapes brain activity. Cell Metabolism, 33(8), 1546–1564. https://doi.org/10.1016/j.cmet.2021.07.006.

 

Bordoni, L., Petracci, I., Mlodzik-Czyzewska, M., Malinowska, A. M., Szwengiel, A., Sadowski, M., Gabbianelli, R., & Chmurzynska, A. (2022). Mitochondrial DNA and epigenetics: Investigating interactions with the one-carbon metabolism in obesity. Oxidative Medicine and Cellular Longevity, 2022, 9171684. https://doi.org/10.1155/2022/9171684.

 

Büttiker, P., Boukherissa, A., Weissenberger, S., Ptáček, R., Anders, M., Raboch, J., & Stefano, G. B. (2024). Cognitive impact of neurotropic pathogens: Investigating molecular mimicry through computational methods. Cellular and Molecular Neurobiology, 44(1), 72. https://doi.org/10.1007/s10571-024-01509-x.

 

Chang, J. P.-C., Mondelli, V., Satyanarayanan, S. K., Chiang, Y. J., Chen, H. T., Su, K. P., & Pariante, C. M. (2020). Cortisol, inflammatory biomarkers, and neurotrophins in children with ADHD in Taiwan. Brain, Behavior, and Immunity, 88, 105–113. https://doi.org/10.1016/j.bbi.2020.05.017.

 

Deepmala, Slattery, J., Kumar, N., Delhey, L., Berk, M., Dean, O. Spielholz, C., & Frye, R. (2015). N-Acetylcysteine in psychiatry and neurology: A systematic review. Neuroscience and Biobehavioral Reviews, 55, 294–317. https://doi.org/10.1016/j.neubiorev.2015.04.015.

 

Dunn, G. A., Nigg, J. T., & Sullivan, E. L. (2019). Neuroinflammation as a risk factor for ADHD. Pharmacology, Biochemistry, and Behavior, 182, 22–34. https://doi.org/10.1016/j.pbb.2019.05.005.

 

Esch, T., & Stefano, G. B. (2002). Proinflammation: A common denominator or initiator of different pathophysiological disease processes. Medical Science Monitor, 8(5), HY1–HY9.

 

Esch, T., Stefano, G. B., Fricchione, G. L., & Benson, H. (2002). The role of stress in neurodegenerative diseases and mental disorders. Neuroendocrinology Letters, 23(3), 199–208.

 

Giannoulis, S. V., Müller D., Kennedy, J. L., & Gonçalves V. (2022). Systematic review of mitochondrial genetic variation in ADHD. European Child & Adolescent Psychiatry. https://doi.org/10.1007/s00787-022-02030-6.

 

Han, V. X., Patel, S., Jones, H. F., & Dale, R. C. (2021). Maternal immune activation and neuroinflammation in human neurodevelopmental disorders. Nature Reviews Neurology, 17(9), 564–579.

 

Innes, J. K., & Calder, P. C. (2018). Omega-6 fatty acids and inflammation. Prostaglandins, leukotrienes, and essential fatty acids, 132, 41–48. https://doi.org/10.1016/j.plefa.2018.03.004.

 

Khan, R., Naveed, S., Mian, N., Fida, A., Raafey, M. A., & Aedma, K. K. (2020). The therapeutic role of cannabidiol in mental health: A systematic review. Journal of Cannabis Research, 2(1), 2.

 

Khazdouz, M., Safarzadeh, R., Hejrani, B., Hasani, M., Mahdavi, F. S., Ejtahed, H. S., & Qorbani, M. (2024). The association between junk foods consumption and attention deficit hyperactivity disorder in children and adolescents: a systematic review and meta-analysis of observational studies. European child & adolescent psychiatry, 10.1007/s00787-024-02521-8. Advance online publication.

 

Kim, J. H., Kim, J. Y., Lee, J., Jeong, G. H., Lee, E., Lee, S., Lee, K. H., Kronbichler, A., Stubbs, B., Solmi, M., Koyanagi, A., Hong, S. H., Dragioti, E., Jacob, L., Brunoni, A. R., Carvalho, A. F., Radua, J., Thompson, T., Smith, L., Oh, H., … Fusar-Poli, P. (2020). Environmental risk factors, protective factors, and peripheral biomarkers for ADHD: an umbrella review. The lancet. Psychiatry, 7(11), 955–970.

 

Konikowska, K., Regulska-Ilow, B., & Rózańska, D. (2012). The influence of components of diet on symptoms of ADHD in children. Roczniki Panstwowego Zakladu Higieny, 63(2), 127–134.

 

Lopez-Leon, S., Wegman-Ostrosky, T., Perelman, C., Sepulveda, R., Rebolledo, P. A., Cuapio, A., & Villapol, S. (2021). More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Scientific reports, 11(1), 16144. https://doi.org/10.1038/s41598-021-95565-8.

 

Maugeri, A., & Barchitta, M. (2020). How dietary factors affect DNA methylation. Medicina (Kaunas), 56(8), 374. https://doi.org/10.3390/medicina56080374.

 

Navarrete, F., García-Gutiérrez, M. S., Jurado-Barba, R., Rubio, G., Gasparyan, A., Austrich-Olivares, A., & Manzanares, J. (2020). Endocannabinoid System Components as Potential Biomarkers in Psychiatry. Frontiers in psychiatry, 11, 315. https://doi.org/10.3389/fpsyt.2020.00315https://doi.org/10.3389/fpsyt.2020.00315.

 

Naviaux, R. K. (2014). Metabolic features of the cell danger response. Mitochondrion, 16, 7–17. https://doi.org/10.1016/j.mito.2013.08.006.

 

Nigg, J. T. (2013). Attention-deficit/hyperactivity disorder and adverse health outcomes. Clinical Psychology Review, 33(2), 215–228. https://doi.org/10.1016/j.cpr.2012.11.005.

 

Oades, R. D., Dauvermann, M.R., Schimmelmann, B.G., Schwarz, M.J., & Myint, A.-M. (2010). Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism - effects of medication. Behavioral and Brain Functions, 6(1), 29. https://doi.org/10.1186/1744-9081-6-29.

 

Park, J.H. (2022). Potential Inflammatory Biomarker in Patients with Attention Deficit Hyperactivity Disorder. Int. J. Mol. Sci., 23, 13054. https://doi.org/10.3390/ijms232113054.

 

Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007). The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis. American Journal of Psychiatry, 164(6), 942–948. https://doi.org/10.1176/ajp.2007.164.6.942.

 

Rios-Hernandez, A., Alda, J.A., Farran-Codina, A., Ferreira-García, E., & Izquierdo-Pulido, M. (2017). The Mediterranean Diet and ADHD in Children and Adolescents. Pediatrics, 139(2), e20162027. https://doi.org/10.1542/peds.2016-2027.

 

Sanchez, C. E., Barry, C., Sabhlok, A., Russell, K., Majors, A., Kollins, S. H., & Fuemmeler, B. F. (2018). Maternal pre-pregnancy obesity and child neurodevelopmental outcomes: a meta-analysis. Obesity Reviews, 19(4), 464–484. https://doi.org/10.1111/obr.12643.

 

Stefano, G. B. (2021). Historical insight into infections and disorders associated with neurological and psychiatric sequelae similar to long COVID. Medical Science Monitor 27, e931447, https://doi.org/10.12659/MSM.931447.

 

Stefano, G. B. (2024). Viral targeting of mitochondria may alter cognition and enhance viral transmission. The Mind - Bulletin on Mind-Body Medicine Research 2, https://doi.org/10.61936/themind/202406043.

 

Stefano, G. B., Pilonis, N., Ptáček, R., Raboch, J., Vnukova, M., & Kream, R. M. (2018). Gut, microbiome, and brain regulatory axis: Relevance to neurodegenerative and psychiatric disorders. Cellular and Molecular Neurobiology, 38(6), 1197–1206. https://doi.org/10.1007/s10571-018-0589-2.

 

Stefano, G. B., Weissenberger, S., Ptáček, R., Anders, M., Raboch, J., & Büttiker, P. (2024). Viruses and mitochondrial dysfunction in neurodegeneration and cognition: An evolutionary perspective. Cellular and Molecular Neurobiology, 44(1), 68. https://doi.org/10.1007/s10571-024-01503-3.

 

Tabatadze, T., Kherkheulidze, M., Kandelaki, E., Kavlashvili, N., & Ivanashvili, T. (2018). ATTENTION DEFICIT HYPERACTIVITY DISORDER AND HAIR HEAVY METAL AND ESSENTIAL TRACE ELEMENT CONCENTRATIONS. IS THERE A LINK?. Georgian medical news, (284), 88–92.

 

Varlaet, C., Maasakkers, C., Hermans, N., & Savelkoul, H. (2018). Rationale for dietary antioxidant treatment of ADHD. Nutrients, 10(4), 405. https://doi.org/10.3390/nu10040405.

 

Wang, S., & Qi, X. (2022). The putative role of astaxanthin in neuroinflammation modulation: Mechanisms and therapeutic potential. Frontiers in Pharmacology, 13, 916653. https://doi.org/10.3389/fphar.2022.916653.

 

Weissenberger, S., Ptacek, R., Klicperova-Baker, M., Erman, A., Schonova, K., Raboch, J., & Goetz M. (2017). ADHD, lifestyles and comorbidities: a call for an holistic perspective - from medical to societal intervening factors. Frontiers in Psychology, 8, 454. https://doi.org/10.3389/fpsyg.2017.00454.

 

Weissenberger, S., Ptáček, R., Vnukova, M., Raboch, J., Klicperova-Baker, M., Domkarova, L., & Goetz, M. (2018). ADHD and lifestyle habits in Czech adults, a national sample. Neuropsychiatric Disease and Treatment, 14, 293–299. https://doi.org/10.2147/NDT.S148921.